NASDAQ:SBPH - Spring Bank Pharmaceuticals SEC Filings & 10K Form

$3.58
+0.01 (+0.28 %)
(As of 09/19/2019 06:52 AM ET)
Today's Range
$3.53
Now: $3.58
$3.74
50-Day Range
$3.62
MA: $3.99
$4.90
52-Week Range
$3.53
Now: $3.58
$15.00
Volume22,300 shs
Average Volume18,387 shs
Market Capitalization$58.93 million
P/E RatioN/A
Dividend YieldN/A
Beta0.51

SEC Filings

Spring Bank Pharmaceuticals (NASDAQ:SBPH) SEC Filings

DateFilerForm TypeView
09/04/2019
7:30 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:01 PM
Spring Bank Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2019
8:01 AM
Smith Scott Andrew (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:59 AM
Klein Pamela M. (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:58 AM
Eichler Kurt M (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:56 AM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:55 AM
Brady Todd C (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:52 AM
Arkowitz David (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:49 AM
Klein Pamela M. (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2019
3:15 PM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
8:04 AM
Smith Scott Andrew (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
8:03 AM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
8:00 AM
Brady Todd C (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
7:58 AM
Arkowitz David (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
2:25 PM
Smith Scott Andrew (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
10:22 AM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
9:16 AM
Freve Jonathan (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
3:31 PM
Spring Bank Pharmaceuticals (Filer)
Form DEFA14A
05/24/2019
3:00 PM
Spring Bank Pharmaceuticals (Filer)
Form DEF 14A
05/22/2019
8:10 AM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:30 PM
Spring Bank Pharmaceuticals (Filer)
Form 10-K/A
04/30/2019
2:17 PM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:07 AM
Spring Bank Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2019
7:00 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
3:05 PM
Smith Scott Andrew (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:04 PM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:03 PM
Brady Todd C (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:03 PM
Arkowitz David (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
5:06 AM
Spring Bank Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2019
10:30 AM
Spring Bank Pharmaceuticals (Filer)
Form CT ORDER
02/14/2019
2:18 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Spring Bank Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2019
7:45 PM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:44 PM
Freve Jonathan (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:40 PM
Iyer Radhakrishnan P. (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:35 PM
Afdhal Nezam H. (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:32 PM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:15 PM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
7:01 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2018
3:17 PM
Spring Bank Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2018
1:28 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Spring Bank Pharmaceuticals (Subject)
Form SC 13G
10/03/2018
3:25 PM
BARDON CHRISTIANA (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
3:04 PM
Eichler Kurt M (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
3:02 PM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
3:50 PM
Smith Scott Andrew (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
3:46 PM
Smith Scott Andrew (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2018
3:00 PM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2018
3:04 PM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:01 PM
Spring Bank Pharmaceuticals (Filer)
Form 424B5
08/08/2018
3:03 PM
Spring Bank Pharmaceuticals (Filer)
Form 424B5
08/02/2018
7:00 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
6:01 AM
Spring Bank Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/02/2018
5:06 AM
Spring Bank Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/03/2018
8:11 AM
Eichler Kurt M (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
8:01 AM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
7:59 AM
BARDON CHRISTIANA (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:39 PM
BARDON CHRISTIANA (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:37 PM
Arkowitz David (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:30 PM
Bates Jonathan (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:28 PM
Brady Todd C (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:26 PM
Eichler Kurt M (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:21 PM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2018
4:00 PM
Spring Bank Pharmaceuticals (Filer)
Form 10-Q/A
04/27/2018
3:05 PM
Spring Bank Pharmaceuticals (Filer)
Form DEFA14A
04/27/2018
3:00 PM
Spring Bank Pharmaceuticals (Filer)
Form DEF 14A
04/27/2018
8:15 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2018
8:15 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2018
8:46 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2018
3:13 PM
BARDON CHRISTIANA (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:11 PM
Eichler Kurt M (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2018
8:00 AM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
3:30 PM
Spring Bank Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
3:25 PM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
3:18 PM
CLACKSON TIMOTHY P (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/01/2018
3:01 PM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
3:14 PM
Spring Bank Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2018
1:31 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Spring Bank Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2018
3:02 PM
Iyer Radhakrishnan P. (Filed by)
Spring Bank Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2018
3:00 PM
Eichler Kurt M (Filed by)
Spring Bank Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2018
3:11 PM
MPM Oncology Impact Management GP LLC (Reporting)
MPM Oncology Impact Management LP (Reporting)
Oncology Impact Fund Management L.P. (0001721036) (Reporting)
Spring Bank Pharmaceuticals (Issuer)
UBS Oncology Impact Fund L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2018
3:08 PM
Spring Bank Pharmaceuticals (Subject)
UBS Oncology Impact Fund L.P. (Filed by)
Form SC 13G/A
01/17/2018
3:06 PM
Iyer Radhakrishnan P. (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2018
3:05 PM
Freve Jonathan (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2018
3:04 PM
Driscoll Martin J (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2018
3:03 PM
Afdhal Nezam H. (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2018
3:14 PM
Eichler Kurt M (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2018
3:12 PM
Brady Todd C (Reporting)
Spring Bank Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel